Effect of therapy on platelet activating factor-induced aggregation in acute stroke

Stroke

Volumn 20, Issue 5, 1989, Pages 609-611

  Joseph, Rajiv ^a   Welch, K ^a   D ' Andrea G ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Aspirin; Cerebrovascular disorders; Platelet activating factor

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; THROMBOCYTE ACTIVATING FACTOR;

ADULT; AGED; CLINICAL ARTICLE; ETHNIC OR RACIAL ASPECTS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; STROKE; THROMBOCYTE AGGREGATION;

ASPIRIN; CEREBROVASCULAR DISORDERS; DIPYRIDAMOLE; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; MALE; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024402719     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.20.5.609     Document Type: Article

References (33)

1. Joseph R, D’Andrea G, Oster SB, Welch KMA: Whole blood platelet function in acute ischemic stroke: Importance of dense body secretion and effects of antithrombotic agents. Stroke 1989;20:38-44
2. Gent M: Single studies and overview analyses: Is aspirin of value in cerebral ischemia? Stroke 1987;18:541-544
3. Bourgain RH, Maes L, Braquet P, Andries R, Touqui L, Braquet M: The effect of l-O-alkyl-2-acetyl-i/t-glyceryl-3-phosphocholine (PAF-acether) on the arterial wall. Prostaglandins 1985;30:185-197
4. Born GVR: Quantitative investigations into the aggregation of blood platelets. J Physiol 1962;162:67-68
5. Joseph R, Welch KMA, D’Andrea G, Levine SR: Sensitivity to PAF is increased in migraine patients Getter). Thromb Haemost 1987;57:125
6. Joseph R, Steiner TJ, Schultz LUC, Rose FC: Platelet activity and selective β-blockade in migraine prophylaxis. Stroke 1988;19:704-708
7. Joseph R, Welch KMA, D’Andrea G, Riddle JM: Evidence for the presence of red and white cells within “platelet” aggregates formed in whole blood. Thromb Res (in press)
8. Joseph R, Welch KMA, D’Andrea G, Riddle JM: Platelet activating factor and red blood cells. Thromb Res (in press)
9. Hanahan DJ: Platelet activating factor: A biologically active phosphoglyceride. Annu Rev Biochem 1986,55:483-509
10. Joseph R, Welch KMA, Grunfeld S, Oster SB, D’Andrea G: Baseline and activated cytoplasmic ionized calcium in acute ischemic stroke: Effect of aspirin. Stroke 1988;19:1234-1238
11. Kuster LJ, Filep J, Frolich JC: Mechanism of PAF-induced platelet aggregation in man. Thromb Res 1986;43:425-433
12. Lam SC-T, Guccione MA, Packham MA, Mustard JF: Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleotide diphosphokinase activity of rabbit platelets. Thromb Haemost 1982;47:90-95
13. Emmons PR, Harrison MJG, Honour AJ, Mitchell JRA: Effect of dipyridamole on human platelet behavior. Lancet 1965;2:603-606
14. Rajah SM, Grow MJ, Penney AF, Ahmad R, Watson DA: The effect of dipyridamole on platelet function: Correlation with blood levels in man. Br J Clin Pharmacol 1977;4:129-133
15. Fitzgerald GA: Dipyridamole. N Engl J Med 1987; 316:1247-1236
16. Lepran I, Lefer AM: Ischemia aggravating effects of platelet-activating factor in acute myocardial ischemia. Basic Res Cardiol 1985;80: 135-141
17. Montrucchio G, Camussi G, Tetta C, Emanuellt G, Orzan F, Libero L, Brusca A: Intravascular release of platelet-activating factor during atrial pacing. Lancet 1986;2:293
18. Benveniste J: PAF-acether (platelet-activating factor). Adv Prostaglandin Thromboxane Leukotriene Res 1985;13:11-18
19. Benveniste J, Chignard M: A role for PAF-acether (platelet-activating factor) in platelet-dependent vascular diseases? Circulation 1985;72:713-717
20. Chignard M, Le Couedic JP, Tence M, Vargaftig BB, Benvenisle J: The role of platelet-activating factor in platelet aggregation. Nature 1979;279:799-800
21. Livio M, Vigano G, Morigi M, Ubiali A, Galbusera M, Remuzzi G: Role of platelet-activating factor in primary hemostasis. Am J Physiol 1988;254:H1218-H1223
22. Vargaftig BB, Fouque F, Benveniste J, Odiot J: Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets. Thromb Res 1982;28:557-573
23. Satoh K, Imaizumi T, Kawamura Y, Yoshida H, Takamatsu S, Mizono S: Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease. Prostaglandins 1988;35:685-697
24. Komecki E, Ehrlich YH: Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor. Science 1988;240:1792-1794
25. Armstead WM, Pourcyrous M, Mirro R, Leffler CW, Busija DW: Platelet activating factor A potent constrictor of cerebral arterioles in newborn pigs. Cire Res 1988;62:1-7
26. Kochanek PM, Nemoto EM, Melick JA, Evans RW, Burke DF: Platelet-activating factor-induced hypotension alters cerebral blood flow and metabolism in rats (abstract). Stroke 1988;19:142
27. Domingo MT, Spinnewyn B, Chabrier PE, Braquet P: Presence of specific binding sites for platelet-activating factor (PAF) in brain. Biochem Biophys Res Commun 1988; 151:730-736
28. Simon MF, Chap H, Braquet P, Douste-Blazy L: Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets. Thromb Res 1987;45:299-309
29. Chung KF, McCusker M, Page CP, Dent G, Guinot P, Barnes PJ: Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses on platelet activating factor in man. Lancet 1987;1:248-250
30. Kochanek PM, Dutka AJ, Kumaroo KK, Hallenbeck JM: Platelet activating factor receptor blockade enhances recovery after multifocal brain ischemia. Life Sci 1987;41:2639-2644
31. Terashita Z-I, Tsuchima S, Yoshioka Y, Nomura H, Inada Y, Nishikawa K: CV-3988. A specific antagonist of platelet-activating factor (PAF). Life Sci 1982;32:1975-1982
32. Bussolino F, Biffignandi P, Arese P: Platelet-activating factor-A powerful lipid autacoid possibly involved in microangiopathy. Acta Haematol (Basel) 1986;75:129-140
33. Hwang S-B, Li C-L, Lam M-H, Shen T-Y: Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist. Lab Invest 1985;52:159-168